Envestnet Asset Management
CRBU icon

Envestnet Asset Management’s Caribou Biosciences CRBU Stock Holding History

Envestnet Asset Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-30,586
Closed -$58.1K – 4849
2026
Q1 		$58.1K Sell
30,586
-1,721
-5% -$2.95K ﹤0.01% 4661
2025
Q4 		$51.4K Sell
32,307
-6,461
-17% -$13.6K ﹤0.01% 4415
2025
Q3 		$90.3K Sell
38,768
-279,889
-88% -$528K ﹤0.01% 4437
2025
Q2 		$402K Buy
318,657
+274,812
+627% +$270K ﹤0.01% 3862
2025
Q1 		$40K Sell
43,845
-2,456
-5% -$3.19K ﹤0.01% 4304
2024
Q4 		$73.6K Buy
46,301
+14,021
+43% +$28.2K ﹤0.01% 4239
2024
Q3 		$63.3K Sell
32,280
-868
-3% -$1.78K ﹤0.01% 4166
2024
Q2 		$54.4K Buy
+33,148
New +$106K ﹤0.01% 4099

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Envestnet Asset Management's CRBU Position: Q2 2026 in Review

Envestnet Asset Management sold out of Caribou Biosciences (CRBU) in Q2 2026, closing a stake of 30,586 shares — an estimated $58.1K sold.

Envestnet Asset Management first reported a position in CRBU in Q2 2024 and held it in 8 quarters. The position peaked at $402K in Q2 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Envestnet Asset Management reported no remaining Caribou Biosciences position as of Q2 2026 after selling out during the quarter.
  • Envestnet Asset Management sold 30,586 Caribou Biosciences shares in Q2 2026, an estimated $58.1K.
  • Envestnet Asset Management first reported a position in Caribou Biosciences in Q2 2024 and held it in 8 quarters.
  • Envestnet Asset Management's Caribou Biosciences position peaked at $402K in Q2 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.